PhD, Department of Biomedical Engineering, Peking University.

He joined CASI in 2015 and has worked as an investment analyst and investment manager, and is now an associate director and member of the medical group. 

Mr. Zhang is responsible for the investment in Sciencare, iFLYTEK Healthcare, Wansi Healthcare, etc, He focuses on investments in innovative drugs and medical devices.